Novartis AGNVS
Price as of · delayed, not real-time
A Switzerland-based pharmaceutical manufacturer focused on innovative prescription medicines across oncology, immunology, neuroscience, and cardiovascular diseases. The company generates revenue from a portfolio of patented drugs and late-stage pipeline assets, following the 2023 spin-off of its generics business, Sandoz. Investors closely monitor its clinical trial results, regulatory approvals, and patent expirations, which drive long-term revenue growth and margin stability.
Congressional Interest in Novartis AG (NVS)
14 members of Congress have disclosed 277 trades in Novartis AG (NVS), a Healthcare company. The buy/sell breakdown shows 23 purchases versus 27 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Who in Congress Is Trading NVS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-31 | Alan Armstrong | buy | $1K-$15K |
| 2026-03-30 | Alan Armstrong | buy | $15K-$50K |
| 2026-03-13 | Rohit Khanna | sell | $1K-$15K |
| 2026-03-13 | Rohit Khanna | buy | $1K-$15K |
| 2026-02-13 | Rohit Khanna | buy | $1K-$15K |
| 2025-10-31 | Lisa McClain | sell | $1K-$15K |
| 2025-10-30 | Lisa McClain | buy | $1K-$15K |
| 2025-10-30 | Lisa McClain | sell | $1K-$15K |
| 2025-09-25 | Lisa McClain | sell | $1K-$15K |
| 2025-09-25 | Lisa McClain | sell | $1K-$15K |
| 2025-09-11 | Lisa McClain | buy | $1K-$15K |
| 2025-09-11 | Lisa McClain | buy | $1K-$15K |
| 2025-07-22 | Lisa McClain | sell | $1K-$15K |
| 2025-06-17 | Lisa McClain | buy | $1K-$15K |
| 2025-06-11 | Lisa McClain | buy | $1K-$15K |
| 2025-06-10 | Lisa McClain | sell | $1K-$15K |
| 2025-06-09 | Lisa McClain | buy | $1K-$15K |
| 2025-03-24 | George Whitesides | sell | $100K-$250K |
| 2024-04-09 | Sheldon Whitehouse | sell | $1K-$15K |
| 2023-09-20 | Sheldon Whitehouse | buy | $15K-$50K |
| 2023-08-02 | Rohit Khanna | sell | $1K-$15K |
| 2023-07-10 | Daniel Goldman | sell | $50K-$100K |
| 2023-04-26 | Thomas R Carper | buy | $1K-$15K |
| 2023-03-31 | Daniel Goldman | buy | $50K-$100K |
| 2023-02-27 | Daniel Goldman | sell | $15K-$50K |
| 2023-01-31 | Kevin Hern | sell | $1K-$15K |
| 2022-04-11 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2022-03-16 | John Rutherford | sell | $1K-$15K |
| 2022-02-28 | Donald Sternoff Beyer | sell | $1K-$15K |
| 2022-01-27 | Donald Sternoff Beyer | buy | $1K-$15K |
| 2021-12-22 | Donald Sternoff Beyer | sell | $1K-$15K |
| 2021-12-15 | Shelley M Capito | sell | $1K-$15K |
| 2021-09-17 | Donald Sternoff Beyer | sell | $1K-$15K |
| 2020-12-31 | David P. Roe | buy | $1K-$15K |
| 2020-12-22 | David P. Roe | sell | $1K-$15K |
| 2020-11-23 | ALAN S. LOWENTHAL | sell | $15K-$50K |
| 2020-11-23 | ALAN S. LOWENTHAL | sell | $1K-$15K |
| 2020-11-23 | ALAN S. LOWENTHAL | sell | $1K-$15K |
| 2020-11-17 | Donald Sternoff Beyer | buy | $1K-$15K |
| 2020-11-16 | David P. Roe | buy | $1K-$15K |
| 2020-11-09 | David P. Roe | buy | $1K-$15K |
| 2020-11-06 | David P. Roe | buy | $1K-$15K |
| 2020-11-06 | David P. Roe | buy | $1K-$15K |
| 2020-10-06 | David P. Roe | buy | $1K-$15K |
| 2020-10-05 | Donald Sternoff Beyer | sell | $1K-$15K |
| 2020-10-05 | David P. Roe | sell | $1K-$15K |
| 2020-10-05 | David P. Roe | sell | $1K-$15K |
| 2020-08-13 | David P. Roe | buy | $15K-$50K |
| 2020-07-27 | Kevin Hern | buy | $1K-$15K |
| 2020-07-14 | Donald Sternoff Beyer | sell | $1K-$15K |